Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP687681.RAjXeOCbQvnONHViCP-H94uQdAAVXnB-U36OBbAvbvoRU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP687681.RAjXeOCbQvnONHViCP-H94uQdAAVXnB-U36OBbAvbvoRU130_assertion type Assertion NP687681.RAjXeOCbQvnONHViCP-H94uQdAAVXnB-U36OBbAvbvoRU130_head.
- NP687681.RAjXeOCbQvnONHViCP-H94uQdAAVXnB-U36OBbAvbvoRU130_assertion description "[Using this assay, the TTV genome load in peripheral blood mononuclear cells (PBMCs) of healthy control subjects (n = 50) and patients with various types of cancer (n = 148), including breast cancer, non-Hodgkin's lymphoma, colon cancer, hepatocellular carcinoma, nasopharyngeal carcinoma, and other cancers, was measured.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP687681.RAjXeOCbQvnONHViCP-H94uQdAAVXnB-U36OBbAvbvoRU130_provenance.
- NP687681.RAjXeOCbQvnONHViCP-H94uQdAAVXnB-U36OBbAvbvoRU130_assertion evidence source_evidence_literature NP687681.RAjXeOCbQvnONHViCP-H94uQdAAVXnB-U36OBbAvbvoRU130_provenance.
- NP687681.RAjXeOCbQvnONHViCP-H94uQdAAVXnB-U36OBbAvbvoRU130_assertion SIO_000772 11708500 NP687681.RAjXeOCbQvnONHViCP-H94uQdAAVXnB-U36OBbAvbvoRU130_provenance.
- NP687681.RAjXeOCbQvnONHViCP-H94uQdAAVXnB-U36OBbAvbvoRU130_assertion wasDerivedFrom befree-20140225 NP687681.RAjXeOCbQvnONHViCP-H94uQdAAVXnB-U36OBbAvbvoRU130_provenance.
- NP687681.RAjXeOCbQvnONHViCP-H94uQdAAVXnB-U36OBbAvbvoRU130_assertion wasGeneratedBy ECO_0000203 NP687681.RAjXeOCbQvnONHViCP-H94uQdAAVXnB-U36OBbAvbvoRU130_provenance.